High speed can make stealth fighter jets like the F-117 more visible to radar due to the plane's unstable aerodynamics and ...
SOFREP on MSNOpinion
Red Eagles: The Secret Guardians of Groom Lake
From hypersonic ghosts scribbling donuts-on-a-rope across the Texas sky to F-16s without tail codes and dark Ghost Hawks ...
Yarnhub on MSN
When a Nighthawk Was Shot Down Over Serbia
On March 27th, 1999, we follow Lt. Col. Darrell Zelko of the USAF 49th Fighter Wing as he flies an F-117A Nighthawk over ...
Plan a Palm Springs outing with attractions like windmill tours, Moorten Botanical Garden, a surf park, the aerial tramway, ...
A Lockheed Martin F-35A stealth fighter from the US Air Force (USAF) test dropped multiple inert versions of a nuclear bomb in August. The USA’s Sandia National Laboratories, a Honeywell subsidiary ...
In March 2025, the United States Air Force made the announcement that Boeing, not Lockheed Martin, will build its new, state-of-the-art F-47 fighter jet, America's first sixth-generation stealth ...
For the first time, Lockheed Martin F-35 stealth fighters have taken the lead in NATO’s annual nuclear readiness drills. Known as Steadfast Noon, the alliance’s yearly nuclear deterrent exercise runs ...
In March of 2025, the U.S. Air Force announced that it had selected the contractor for its sixth-generation stealth fighter program: not Lockheed Martin, which made the F-22 and still makes the F-35, ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The F-22 Raptor began a new era of aircraft in 2005–the ...
The Navy intends for the sixth-generation F/A-XX to replace the aging F/A-18 and E/A-18 aircraft. Defense Secretary Pete Hegseth has reportedly approved plans to advance the Navy’s F/A-XX ...
Boeing has begun building the U.S. Air Force’s next generation stealth fighter and intends to fly it for the first time in 2028, Gen. David Allvin, the Air Force chief of staff, said Monday. Allvin’s ...
After a tumultuous journey filled with delays and rejection, the FDA has approved Stealth BioTherapeutics’ treatment for the ultrarare disease Barth syndrome, marking the peptide as the first therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results